Curcumin Extract for Prevention of Type 2 Diabetes
To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population. This randomized, double-blinded, placebo- controlled trial included subjects (n = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curc...
Saved in:
Published in | Diabetes care Vol. 35; no. 11; pp. 2121 - 2127 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.11.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population.
This randomized, double-blinded, placebo- controlled trial included subjects (n = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curcumin or placebo capsules for 9 months. To assess the T2DM progression after curcumin treatments and to determine the number of subjects progressing to T2DM, changes in β-cell functions (homeostasis model assessment [HOMA]-β, C-peptide, and proinsulin/insulin), insulin resistance (HOMA-IR), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention.
After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; P < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; P < 0.001) and higher adiponectin (22.46 vs. 18.45; P < 0.05) when compared with the placebo group.
A 9-month curcumin intervention in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of β-cells, with very minor adverse effects. Therefore, this study demonstrated that the curcumin intervention in a prediabetic population may be beneficial. |
---|---|
AbstractList | To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population.OBJECTIVETo assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population.This randomized, double-blinded, placebo- controlled trial included subjects (n = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curcumin or placebo capsules for 9 months. To assess the T2DM progression after curcumin treatments and to determine the number of subjects progressing to T2DM, changes in β-cell functions (homeostasis model assessment [HOMA]-β, C-peptide, and proinsulin/insulin), insulin resistance (HOMA-IR), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention.RESEARCH DESIGN AND METHODSThis randomized, double-blinded, placebo- controlled trial included subjects (n = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curcumin or placebo capsules for 9 months. To assess the T2DM progression after curcumin treatments and to determine the number of subjects progressing to T2DM, changes in β-cell functions (homeostasis model assessment [HOMA]-β, C-peptide, and proinsulin/insulin), insulin resistance (HOMA-IR), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention.After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; P < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; P < 0.001) and higher adiponectin (22.46 vs. 18.45; P < 0.05) when compared with the placebo group.RESULTSAfter 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; P < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; P < 0.001) and higher adiponectin (22.46 vs. 18.45; P < 0.05) when compared with the placebo group.A 9-month curcumin intervention in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of β-cells, with very minor adverse effects. Therefore, this study demonstrated that the curcumin intervention in a prediabetic population may be beneficial.CONCLUSIONSA 9-month curcumin intervention in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of β-cells, with very minor adverse effects. Therefore, this study demonstrated that the curcumin intervention in a prediabetic population may be beneficial. To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population. This randomized, double-blinded, placebocontrolled trial included subjects (n = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curcumin or placebo capsules for 9 months. To assess the T2DM progression after curcumin treatments and to determine the number of subjects progressing to T2DM, changes in ß-cell functions (homeostasis model assessment [HOMA]-ß, C-peptide, and proinsulin/insulin), insulin resistance (HOMA-IR), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention. After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of ß-cells, with higher HOMA-ß (61.58 vs. 48.72; ? < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; P < 0.001) and higher adiponectin (22.46 vs. 18.45; ? < 0.05) when compared with the placebo group. A 9-month curcumin intervention in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of ß-cells, with very minor adverse effects. Therefore, this study demonstrated that the curcumin intervention in a prediabetic population may be beneficial. [PUBLICATION ABSTRACT] To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population. This randomized, double-blinded, placebo- controlled trial included subjects (n = 240) with criteria of prediabetes. All subjects were randomly assigned to receive either curcumin or placebo capsules for 9 months. To assess the T2DM progression after curcumin treatments and to determine the number of subjects progressing to T2DM, changes in β-cell functions (homeostasis model assessment [HOMA]-β, C-peptide, and proinsulin/insulin), insulin resistance (HOMA-IR), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention. After 9 months of treatment, 16.4% of subjects in the placebo group were diagnosed with T2DM, whereas none were diagnosed with T2DM in the curcumin-treated group. In addition, the curcumin-treated group showed a better overall function of β-cells, with higher HOMA-β (61.58 vs. 48.72; P < 0.01) and lower C-peptide (1.7 vs. 2.17; P < 0.05). The curcumin-treated group showed a lower level of HOMA-IR (3.22 vs. 4.04; P < 0.001) and higher adiponectin (22.46 vs. 18.45; P < 0.05) when compared with the placebo group. A 9-month curcumin intervention in a prediabetic population significantly lowered the number of prediabetic individuals who eventually developed T2DM. In addition, the curcumin treatment appeared to improve overall function of β-cells, with very minor adverse effects. Therefore, this study demonstrated that the curcumin intervention in a prediabetic population may be beneficial. |
Audience | Professional |
Author | Luechapudiporn, Rataya Chuengsamarn, Somlak Rattanamongkolgul, Suthee Jirawatnotai, Siwanon Phisalaphong, Chada |
Author_xml | – sequence: 1 givenname: Somlak surname: Chuengsamarn fullname: Chuengsamarn, Somlak organization: Division of Endocrinology and Metabolism, Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, Nakornnayok, Thailand, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, Boston, Massachusetts – sequence: 2 givenname: Suthee surname: Rattanamongkolgul fullname: Rattanamongkolgul, Suthee organization: Department of Preventive and Social Medicine, Faculty of Medicine, HRH Princess Maha Chakri Sirindhorn Medical Center, Srinakharinwirot University, Nakornnayok, Thailand – sequence: 3 givenname: Rataya surname: Luechapudiporn fullname: Luechapudiporn, Rataya organization: Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand – sequence: 4 givenname: Chada surname: Phisalaphong fullname: Phisalaphong, Chada organization: Research and Development Institute, Thai Government Pharmaceutical Organization, Bangkok, Thailand – sequence: 5 givenname: Siwanon surname: Jirawatnotai fullname: Jirawatnotai, Siwanon organization: Institute of Molecular Biosciences, Mahidol University, Salaya, Nakhon Pratom, Thailand, Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26674746$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22773702$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl1rFDEUhoNU7LZ64R-QARH0Ytp8TjI3hbLWDyjoRb0OmeTMmjKTrMlMsf_eDN1aW5dAAslzXt6c9xyhgxADIPSa4BPKmDx1ltAaE9I8QyvSMlELwdUBWmHC21q0LT1ERzlfY4w5V-oFOqRUSiYxXSG6npOdRx-qi99TMnaq-piq7wluIEw-hir21dXtFipaffSmgwnyS_S8N0OGV7vzGP34dHG1_lJffvv8dX1-WdsG86l23Ha9ZR3BopEMsCRdZx3rnMSSg3XKtoBZq4Ri1ClhaW9w19KyOelwK9kxOrvT3c7dCM4WQ8kMepv8aNKtjsbrxy_B_9SbeKMZl01LaBF4vxNI8dcMedKjzxaGwQSIc9aEEIEbzhQr6Nsn6HWcUyjf04RSpjhngjxQGzOA9qGPS8sWUX3OimUqlcKFqvdQGwhQTJbgel-uH_Ene_iyHIze7i14829j_nbkPtUCvNsBJlsz9MkE6_MD1zSSS94U7vSOsynmnKDX1k9mib048IMmWC_zpZf50st8lYoPTyruRf9n_wBSsMuv |
CODEN | DICAD2 |
CitedBy_id | crossref_primary_10_3177_jnsv_69_299 crossref_primary_10_3390_biom14030310 crossref_primary_10_3389_fnut_2022_962720 crossref_primary_10_1002_mnfr_201300724 crossref_primary_10_2174_1573399819666230314093721 crossref_primary_10_3390_biom12030378 crossref_primary_10_1371_journal_pone_0215840 crossref_primary_10_3390_ijms231911038 crossref_primary_10_3390_antiox4040750 crossref_primary_10_1016_j_abb_2022_109326 crossref_primary_10_1016_j_hermed_2019_100324 crossref_primary_10_1080_14786419_2023_2245115 crossref_primary_10_1038_nrcardio_2013_140_c1 crossref_primary_10_1007_s00394_017_1594_9 crossref_primary_10_1016_j_foodres_2022_111202 crossref_primary_10_1136_bcr_2018_224611 crossref_primary_10_1016_j_jep_2014_12_056 crossref_primary_10_3389_fnut_2022_1040259 crossref_primary_10_1080_07853890_2017_1366042 crossref_primary_10_14218_ERHM_2017_00023 crossref_primary_10_3390_nu14183784 crossref_primary_10_1080_15376516_2016_1253811 crossref_primary_10_1016_j_clnesp_2021_06_006 crossref_primary_10_3390_nu11051004 crossref_primary_10_1186_s40200_017_0317_3 crossref_primary_10_3389_fphys_2022_848867 crossref_primary_10_1080_1061186X_2023_2229961 crossref_primary_10_1080_10408398_2018_1552244 crossref_primary_10_2174_0115733998273029231121094725 crossref_primary_10_1186_s12986_019_0331_1 crossref_primary_10_3389_fnut_2022_865497 crossref_primary_10_1007_s40200_020_00628_8 crossref_primary_10_1177_1933719115625846 crossref_primary_10_1186_s13098_019_0437_7 crossref_primary_10_1016_j_clnu_2014_12_019 crossref_primary_10_1016_j_jksus_2021_101493 crossref_primary_10_1111_ijfs_17236 crossref_primary_10_2174_0929867328666210810142527 crossref_primary_10_3389_fphar_2017_00148 crossref_primary_10_1016_j_drudis_2017_01_006 crossref_primary_10_1016_j_jddst_2023_104377 crossref_primary_10_1111_bph_12854 crossref_primary_10_3389_fcimb_2022_1054205 crossref_primary_10_3390_ijms22041509 crossref_primary_10_1007_s13318_016_0377_7 crossref_primary_10_1136_bmjopen_2017_016914 crossref_primary_10_1093_jmcb_mjx031 crossref_primary_10_3389_fmicb_2022_977292 crossref_primary_10_4162_nrp_2023_17_3_397 crossref_primary_10_1016_j_biochi_2019_03_006 crossref_primary_10_1016_j_tifs_2017_04_001 crossref_primary_10_1016_j_jep_2023_117087 crossref_primary_10_1002_mnfr_201700731 crossref_primary_10_1007_s10787_019_00607_3 crossref_primary_10_1016_j_diabres_2024_111912 crossref_primary_10_4327_jsnfs_76_141 crossref_primary_10_3390_medicines6040107 crossref_primary_10_1038_s41538_021_00119_x crossref_primary_10_2174_0115733998313402240726080637 crossref_primary_10_1017_S0007114523002428 crossref_primary_10_3390_nu12010058 crossref_primary_10_1016_j_promfg_2016_08_039 crossref_primary_10_1038_s41386_018_0295_2 crossref_primary_10_1007_s40200_023_01376_1 crossref_primary_10_3390_nu13020630 crossref_primary_10_1021_acs_jafc_7b03583 crossref_primary_10_1111_dom_14804 crossref_primary_10_1097_FJC_0000000000000406 crossref_primary_10_1080_10408398_2022_2067826 crossref_primary_10_1016_j_jtcme_2017_08_012 crossref_primary_10_1016_j_biopha_2017_10_119 crossref_primary_10_3390_app11178163 crossref_primary_10_1002_mnfr_201400871 crossref_primary_10_1016_j_jnutbio_2018_12_005 crossref_primary_10_1016_j_hermed_2024_100845 crossref_primary_10_3390_molecules190812727 crossref_primary_10_1590_1516_3180_2018_0454120419 crossref_primary_10_1016_j_nut_2016_09_005 crossref_primary_10_1016_j_jep_2017_02_031 crossref_primary_10_1111_bph_13621 crossref_primary_10_2174_1389201021666200305115101 crossref_primary_10_4028_p_7lJFTP crossref_primary_10_1016_j_bcab_2021_102191 crossref_primary_10_1039_D2FO02625B crossref_primary_10_1002_cbdv_202200029 crossref_primary_10_1210_me_2014_1180 crossref_primary_10_1002_mnfr_201501034 crossref_primary_10_1080_17425255_2019_1650914 crossref_primary_10_3390_ijms25147827 crossref_primary_10_2174_2210315512666220512205625 crossref_primary_10_1016_j_drudis_2015_12_001 crossref_primary_10_1139_apnm_2015_0145 crossref_primary_10_1017_jns_2014_3 crossref_primary_10_1016_j_bioorg_2021_104720 crossref_primary_10_1515_jbcpp_2021_0255 crossref_primary_10_1016_j_hermed_2022_100621 crossref_primary_10_3389_fphar_2018_00893 crossref_primary_10_1186_1749_8546_9_3 crossref_primary_10_1016_j_jep_2020_113177 crossref_primary_10_1016_j_bbrc_2017_08_101 crossref_primary_10_1007_s00210_023_02884_w crossref_primary_10_1208_s12248_012_9432_8 crossref_primary_10_1016_j_ejphar_2017_12_004 crossref_primary_10_1080_03639045_2020_1762201 crossref_primary_10_3390_nu12102990 crossref_primary_10_1039_C5RA14925H crossref_primary_10_1016_j_phyplu_2024_100627 crossref_primary_10_1016_j_biopha_2023_116034 crossref_primary_10_1002_ijc_30224 crossref_primary_10_3390_pharmaceutics13030413 crossref_primary_10_1155_2015_629863 crossref_primary_10_1007_s43555_024_00022_y crossref_primary_10_1038_s41392_023_01439_y crossref_primary_10_1111_bph_15018 crossref_primary_10_1186_s13098_022_00828_7 crossref_primary_10_1016_j_jff_2017_03_035 crossref_primary_10_1016_j_biopha_2018_01_111 crossref_primary_10_1038_s41401_023_01176_6 crossref_primary_10_3109_14756366_2015_1101091 crossref_primary_10_3390_molecules24224030 crossref_primary_10_1152_ajpendo_00285_2017 crossref_primary_10_3390_molecules29122934 crossref_primary_10_1111_cei_12322 crossref_primary_10_4236_health_2018_104030 crossref_primary_10_3390_ph16040515 crossref_primary_10_1166_jbmb_2024_2446 crossref_primary_10_3389_fphar_2019_00649 crossref_primary_10_1039_D4MD00023D crossref_primary_10_1142_S0192415X15500524 crossref_primary_10_1002_ptr_7274 crossref_primary_10_1002_dmrr_3762 crossref_primary_10_1159_000520311 crossref_primary_10_3390_molecules19067287 crossref_primary_10_1016_j_dsx_2021_04_002 crossref_primary_10_1016_j_jphotobiol_2016_08_002 crossref_primary_10_1007_s11428_013_1113_4 crossref_primary_10_1016_j_fct_2015_05_022 crossref_primary_10_1016_j_hermed_2021_100430 crossref_primary_10_1016_j_ijbiomac_2015_03_060 crossref_primary_10_3390_ijms151120290 crossref_primary_10_1002_ptr_6054 crossref_primary_10_1002_ptr_7264 crossref_primary_10_20945_2359_3997000000513 crossref_primary_10_1007_s13659_019_0202_5 crossref_primary_10_1016_j_explore_2013_04_010 crossref_primary_10_3390_toxics11100867 crossref_primary_10_2174_0929867329666220322110348 crossref_primary_10_3390_ijerph15102093 crossref_primary_10_33667_2078_5631_2022_16_127_134 crossref_primary_10_3390_nu10101553 crossref_primary_10_1016_j_cca_2015_07_009 crossref_primary_10_1016_j_taap_2021_115772 crossref_primary_10_2174_0929867331666230821102431 crossref_primary_10_1002_jcb_26121 crossref_primary_10_1016_j_ijbiomac_2016_11_050 crossref_primary_10_1002_ptr_5197 crossref_primary_10_4103_0971_5916_184281 crossref_primary_10_1002_ptr_7136 crossref_primary_10_1016_j_bbrc_2013_04_092 crossref_primary_10_1016_j_chmed_2025_02_009 crossref_primary_10_1016_j_phrs_2022_106599 crossref_primary_10_2174_1381612829666230613115447 crossref_primary_10_1080_23311932_2019_1577532 crossref_primary_10_1016_j_phrs_2022_106121 crossref_primary_10_3390_antiox11112294 crossref_primary_10_1016_j_semcancer_2017_05_010 crossref_primary_10_3153_FH21006 crossref_primary_10_1186_s12989_024_00582_w crossref_primary_10_1038_s41598_018_32032_x crossref_primary_10_1515_hmbci_2016_0016 crossref_primary_10_1002_ptr_6037 crossref_primary_10_1016_j_foodhyd_2024_109785 crossref_primary_10_1016_j_ejogrb_2023_12_038 crossref_primary_10_1271_bbb_130254 crossref_primary_10_3389_fphar_2018_00472 crossref_primary_10_1080_10937404_2020_1860842 crossref_primary_10_3390_nu16111728 crossref_primary_10_1007_s10876_022_02230_9 crossref_primary_10_1155_2022_5649156 crossref_primary_10_2174_1573401319666230721105040 crossref_primary_10_1007_s00775_015_1295_x crossref_primary_10_1016_j_gene_2015_02_045 crossref_primary_10_2147_CIA_S457180 crossref_primary_10_3390_nu14061313 crossref_primary_10_3390_ijerph17114088 crossref_primary_10_1016_j_phymed_2012_12_004 crossref_primary_10_1038_aps_2017_179 crossref_primary_10_1002_ptr_8208 crossref_primary_10_1016_j_phanu_2015_08_001 crossref_primary_10_1007_s10528_018_9863_8 crossref_primary_10_3389_fphar_2021_798329 crossref_primary_10_1016_j_dsx_2021_102378 crossref_primary_10_3390_antiox11020353 crossref_primary_10_1016_j_dsx_2023_102855 crossref_primary_10_2147_DMSO_S232791 crossref_primary_10_1080_14756366_2021_1874945 crossref_primary_10_1002_ptr_6370 crossref_primary_10_1016_j_jcm_2014_07_002 crossref_primary_10_3389_fendo_2021_656978 crossref_primary_10_3390_ijms21072440 crossref_primary_10_1039_C7FO01242J crossref_primary_10_3390_nu16121877 crossref_primary_10_1002_ptr_7109 crossref_primary_10_1039_C7FO00178A crossref_primary_10_1007_s11684_019_0729_1 crossref_primary_10_1016_j_joim_2022_02_008 crossref_primary_10_3390_ijms24043323 crossref_primary_10_1097_NT_0000000000000392 crossref_primary_10_1002_mnfr_201200791 crossref_primary_10_1016_j_saa_2023_123281 crossref_primary_10_1016_j_biochi_2013_11_021 crossref_primary_10_1007_s11011_017_0133_y crossref_primary_10_5604_01_3001_0012_8343 crossref_primary_10_3389_fnut_2023_1301129 crossref_primary_10_1016_j_fct_2021_112003 crossref_primary_10_1016_j_ijbiomac_2022_11_038 crossref_primary_10_1016_j_jnim_2018_07_003 crossref_primary_10_1080_21688370_2018_1425085 crossref_primary_10_1155_2021_5563660 crossref_primary_10_1016_j_clnesp_2020_01_005 crossref_primary_10_3892_mmr_2017_8085 crossref_primary_10_1016_j_biopha_2023_115463 crossref_primary_10_1016_j_neubiorev_2019_09_025 crossref_primary_10_1002_med_21440 crossref_primary_10_1155_2018_9698258 crossref_primary_10_3390_ijms18061188 crossref_primary_10_1055_a_2157_8913 crossref_primary_10_1002_ptr_7564 crossref_primary_10_1016_j_diabres_2017_05_024 crossref_primary_10_1016_j_drudis_2013_04_009 crossref_primary_10_29328_journal_acem_1001026 crossref_primary_10_1016_j_phrs_2014_10_004 crossref_primary_10_1080_07315724_2016_1267597 crossref_primary_10_1186_s12937_024_01022_3 crossref_primary_10_1002_iub_2399 crossref_primary_10_3390_medicina55090603 crossref_primary_10_1002_cbdv_201900176 crossref_primary_10_1155_2015_818570 crossref_primary_10_1111_jfbc_12522 crossref_primary_10_3390_ijerph19116443 crossref_primary_10_1016_j_plipres_2014_07_002 crossref_primary_10_1016_j_molimm_2020_05_017 crossref_primary_10_1016_j_ajcnut_2023_03_006 crossref_primary_10_3390_pr9071132 crossref_primary_10_3390_medicina56070336 crossref_primary_10_31590_ejosat_676335 crossref_primary_10_3390_foods6100092 crossref_primary_10_1002_ptr_6226 crossref_primary_10_1007_s00394_018_1766_2 crossref_primary_10_1016_j_phrs_2019_104601 crossref_primary_10_1021_acsptsci_2c00012 crossref_primary_10_2337_diaspect_26_4_259 crossref_primary_10_1002_mnfr_201600471 crossref_primary_10_1002_mnfr_201500940 crossref_primary_10_3177_jnsv_68_S110 crossref_primary_10_1155_2022_1375892 crossref_primary_10_3390_ijms23094589 crossref_primary_10_3390_ijms24054476 crossref_primary_10_1016_j_fbio_2025_106406 crossref_primary_10_1007_s10549_015_3512_2 crossref_primary_10_3390_nu13061848 crossref_primary_10_1039_D3FO05122F crossref_primary_10_1177_2472630317751840 crossref_primary_10_1186_s12944_019_0967_x crossref_primary_10_1002_ptr_6323 crossref_primary_10_1002_ptr_6324 crossref_primary_10_1186_s42269_019_0164_0 crossref_primary_10_1002_fft2_15 crossref_primary_10_1002_ptr_6328 crossref_primary_10_1080_10408398_2018_1517724 crossref_primary_10_1016_j_dsx_2018_11_051 crossref_primary_10_1155_2017_1813086 crossref_primary_10_1016_j_jaim_2021_04_010 crossref_primary_10_1007_s40495_021_00255_8 crossref_primary_10_1016_j_hermed_2021_100531 crossref_primary_10_1021_acs_jafc_0c00131 crossref_primary_10_1053_j_jrn_2016_01_013 crossref_primary_10_3390_antiox10050808 crossref_primary_10_1016_j_ejphar_2015_02_045 crossref_primary_10_3390_nu13082654 crossref_primary_10_3390_foods12050925 crossref_primary_10_1155_2020_1356893 crossref_primary_10_1002_jcp_25795 crossref_primary_10_1038_s41598_024_74750_5 crossref_primary_10_1111_jre_13200 crossref_primary_10_1016_j_orcp_2019_04_003 crossref_primary_10_2478_fzm_2022_0030 crossref_primary_10_3390_nu14163301 crossref_primary_10_3390_nu14010175 crossref_primary_10_1530_JME_17_0151 crossref_primary_10_1371_journal_pone_0288997 crossref_primary_10_2174_0118741045349977241125104444 crossref_primary_10_1111_andr_13687 crossref_primary_10_3390_pharmaceutics14051021 crossref_primary_10_1016_j_ctim_2014_07_006 crossref_primary_10_1080_14786419_2020_1821019 crossref_primary_10_1016_j_ctim_2019_02_014 crossref_primary_10_1155_2013_378657 crossref_primary_10_13050_foodengprog_2017_21_3_273 crossref_primary_10_1007_s40290_019_00289_w crossref_primary_10_1021_acs_inorgchem_7b01924 crossref_primary_10_1177_23779608231175581 crossref_primary_10_1016_j_jddst_2023_104723 crossref_primary_10_1016_j_prmcm_2023_100222 crossref_primary_10_1002_biof_1522 crossref_primary_10_3389_fnut_2021_717343 crossref_primary_10_1016_j_biochi_2019_08_013 crossref_primary_10_1016_j_lfs_2019_117032 crossref_primary_10_1039_C7MT00282C crossref_primary_10_1186_s13063_020_04923_w crossref_primary_10_3390_biom14020234 crossref_primary_10_3390_nu12041032 crossref_primary_10_1186_s13063_018_3032_6 crossref_primary_10_2147_IJN_S487519 crossref_primary_10_1016_j_matpr_2021_01_299 crossref_primary_10_2174_1568026623666230428101440 crossref_primary_10_1002_ptr_7974 crossref_primary_10_3390_molecules28103996 crossref_primary_10_1016_j_foodchem_2016_08_111 crossref_primary_10_3390_ijms25158481 crossref_primary_10_1016_j_ctim_2019_102201 crossref_primary_10_1016_j_foodres_2024_115084 crossref_primary_10_3390_ijms242115906 crossref_primary_10_1038_s41598_022_14241_7 crossref_primary_10_2174_1573406418666220509101854 crossref_primary_10_1016_j_eujim_2021_101400 crossref_primary_10_1016_j_ijbiomac_2015_09_026 crossref_primary_10_1155_2014_458592 crossref_primary_10_1007_s40292_017_0206_3 crossref_primary_10_1016_j_ejmech_2019_04_058 crossref_primary_10_1016_j_fbio_2024_104550 crossref_primary_10_2174_1573399819666221124104401 crossref_primary_10_1016_j_bbrc_2015_09_018 crossref_primary_10_1016_j_jep_2016_10_039 crossref_primary_10_1016_j_bbadis_2014_11_006 crossref_primary_10_1248_yakushi_18_00091_2 crossref_primary_10_3390_molecules27134058 crossref_primary_10_1038_cddis_2016_455 crossref_primary_10_3390_jcm9030746 crossref_primary_10_1016_j_jnim_2018_05_001 crossref_primary_10_1016_j_jnutbio_2020_108515 crossref_primary_10_1371_journal_pone_0059003 crossref_primary_10_3390_ijms24076621 crossref_primary_10_1016_j_dsx_2019_07_045 crossref_primary_10_1016_j_phymed_2018_04_045 crossref_primary_10_1016_j_phrs_2017_09_010 crossref_primary_10_3390_nu13020680 crossref_primary_10_1186_s12906_022_03515_2 crossref_primary_10_1007_s42399_021_01034_8 crossref_primary_10_1093_advances_nmaa161 crossref_primary_10_1002_oby_22110 crossref_primary_10_4236_ajps_2021_123030 crossref_primary_10_2174_0929867330666230519112312 crossref_primary_10_3136_fstr_FSTR_D_21_00264 crossref_primary_10_1002_fsn3_4469 crossref_primary_10_1155_2014_898361 crossref_primary_10_1002_ptr_5659 crossref_primary_10_1002_ptr_6749 crossref_primary_10_1080_10408398_2022_2103088 crossref_primary_10_1007_s13273_021_00144_7 crossref_primary_10_2174_1573406416666200506083718 crossref_primary_10_1080_13813455_2019_1657899 crossref_primary_10_1155_2017_4826724 crossref_primary_10_31590_ejosat_762959 crossref_primary_10_1016_j_tice_2025_102852 crossref_primary_10_3390_nu14061189 crossref_primary_10_1155_2013_636053 crossref_primary_10_22246_jikm_2019_40_1_13 crossref_primary_10_1016_j_diabres_2017_02_019 crossref_primary_10_1530_JOE_14_0335 crossref_primary_10_3389_fphar_2022_876614 crossref_primary_10_4093_dmj_2022_0416 crossref_primary_10_1093_nutrit_nuab034 crossref_primary_10_1016_j_ctim_2017_05_006 crossref_primary_10_1016_j_jnutbio_2025_109897 crossref_primary_10_1097_MCO_0000000000000227 crossref_primary_10_1038_s41387_024_00274_6 crossref_primary_10_3390_scipharm91040053 crossref_primary_10_1016_j_jddst_2020_101885 crossref_primary_10_3390_ijms20153815 crossref_primary_10_1016_j_nut_2016_03_018 crossref_primary_10_1097_MPA_0000000000002290 crossref_primary_10_1186_1475_2891_13_11 crossref_primary_10_3945_jn_115_216853 crossref_primary_10_1080_13880209_2019_1594311 crossref_primary_10_3390_nu11081837 crossref_primary_10_1155_2019_8208237 crossref_primary_10_1016_j_bbagen_2017_03_017 crossref_primary_10_1002_ptr_7800 crossref_primary_10_1016_j_jff_2017_06_023 crossref_primary_10_1016_j_freeradbiomed_2023_08_009 crossref_primary_10_1016_j_jchromb_2015_01_014 crossref_primary_10_1186_s13098_019_0431_0 crossref_primary_10_1002_biof_1302 crossref_primary_10_3390_nu4121868 crossref_primary_10_61186_jmp_22_86_1 crossref_primary_10_1186_1475_2891_12_36 crossref_primary_10_1111_jhn_12648 crossref_primary_10_1039_D1FO02696H crossref_primary_10_1111_bph_12131 crossref_primary_10_1155_2016_6043601 crossref_primary_10_3390_life11020079 crossref_primary_10_1155_2024_8563066 crossref_primary_10_1007_s11332_017_0402_5 crossref_primary_10_1007_s10549_023_07223_4 crossref_primary_10_1155_2020_7656919 crossref_primary_10_2147_DMSO_S247351 crossref_primary_10_1002_mco2_516 crossref_primary_10_1016_j_tifs_2020_03_018 crossref_primary_10_2147_DMSO_S375572 crossref_primary_10_1002_mnfr_201400493 crossref_primary_10_3390_biom14070836 crossref_primary_10_1002_jcp_28528 |
Cites_doi | 10.1038/bjp.2008.311 10.2337/dc09-9033 10.1016/S0140-6736(05)67402-8 10.1152/ajpendo.00104.2002 10.2337/diacare.29.04.06.dc05-2330 10.1089/107555303321223035 10.2337/diacare.26.3.917 10.1007/978-0-387-46401-5_21 10.1210/jcem.85.7.6661 10.1111/j.1463-1326.2006.00704.x 10.1002/mnfr.200700184 10.1016/j.metabol.2008.06.014 10.2337/diacare.27.5.1047 10.1371/journal.pone.0028784 10.1021/jf0483873 10.1007/BF00280883 10.1001/jama.2009.976 10.2337/dc05-2141 10.2337/dc09-1579 10.1089/ars.2008.2140 10.2337/diacare.20.7.1183 10.1016/S0197-2456(98)00037-3 10.1146/annurev.nutr.012809.104755 10.1248/bpb.28.937 10.2337/dc12-s004 10.2337/diacare.26.4.1277 10.1210/jc.2004-2549 10.1210/en.2008-0262 10.1056/NEJMoa012512 |
ContentType | Journal Article |
Copyright | 2014 INIST-CNRS COPYRIGHT 2012 American Diabetes Association Copyright American Diabetes Association Nov 2012 2012 by the American Diabetes Association. 2012 |
Copyright_xml | – notice: 2014 INIST-CNRS – notice: COPYRIGHT 2012 American Diabetes Association – notice: Copyright American Diabetes Association Nov 2012 – notice: 2012 by the American Diabetes Association. 2012 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7RV 7X2 7X7 7XB 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ATCPS AZQEC BEC BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH HCIFZ K9- K9. KB0 M0K M0R M0S M0T M1P M2O M2P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U S0X 7X8 5PM |
DOI | 10.2337/dc12-0116 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database (ProQuest) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central ProQuest Central UK/Ireland British Nursing Database ProQuest SciTech Premium Collection Natural Science Collection Agricultural & Environmental Science Collection ProQuest Central Essentials eLibrary ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Agricultural Science Database Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Research Library (ProQuest) Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Research Library Prep ProQuest Central Student ProQuest Central Essentials elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Health Research Premium Collection Natural Science Collection Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Family Health ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Agricultural & Environmental Science Collection ProQuest Research Library ProQuest Public Health ProQuest Central Basic ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Agricultural Science Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1935-5548 |
EndPage | 2127 |
ExternalDocumentID | PMC3476912 2836377621 A309727880 22773702 26674746 10_2337_dc12_0116 |
Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Thailand |
GeographicLocations_xml | – name: Thailand |
GroupedDBID | --- -ET ..I .XZ 08P 0R~ 18M 29F 2WC 4.4 53G 5GY 5RE 5RS 5VS 6PF 7RV 7X2 7X7 88E 88I 8AF 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8R4 8R5 AAFWJ AAIKC AAKAS AAMNW AAWTL AAYEP AAYXX ABOCM ABPPZ ABUWG ACGFO ACGOD ADBBV ADZCM AEGXH AENEX AERZD AFKRA AFOSN AFRAH AHMBA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 AQUVI ATCPS AZQEC BAWUL BCR BCU BEC BENPR BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BTFSW BVXVI CCPQU CITATION CS3 DIK DU5 DWQXO E3Z EBS EDB EJD EMOBN EX3 F5P FYUFA GNUQQ GUQSH GX1 H13 HCIFZ HMCUK HZ~ IAG IAO IEA IHR INH INR IOF IPO ITC K9- KQ8 L7B M0K M0R M0T M1P M2O M2P M2Q M5~ NAPCQ O5R O5S O9- OK1 OVD P2P PCD PEA PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RHI S0X SJFOW SV3 TDI TEORI TR2 TWZ UKHRP VVN W8F WH7 WOQ WOW YHG YOC ~KM .55 .GJ 3O- 41~ 8F7 AAQOH AAQQT AAYJJ AFFNX AI. C1A IQODW J5H N4W PJZUB PPXIY VH1 WHG X7M ZCG ZGI ZXP 3V. CGR CUY CVF ECM EIF IGG NPM RHF VXZ PMFND 7XB 8FK K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c604t-d4cbfc3b105673e071bbcd3bd7074ecd8c9e03985832d85c2fa0b92a0bd7d0973 |
IEDL.DBID | 7X7 |
ISSN | 0149-5992 1935-5548 |
IngestDate | Thu Aug 21 14:11:09 EDT 2025 Fri Jul 11 09:55:50 EDT 2025 Sat Jul 26 02:36:01 EDT 2025 Tue Jun 17 20:31:26 EDT 2025 Thu Jun 12 23:46:03 EDT 2025 Tue Jun 10 20:37:07 EDT 2025 Wed Feb 19 01:51:37 EST 2025 Mon Jul 21 09:16:10 EDT 2025 Thu Apr 24 23:12:33 EDT 2025 Tue Jul 01 04:11:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Endocrinopathy Type 2 diabetes Human Prevention Nutrition Metabolic diseases Extract Endocrinology |
Language | English |
License | CC BY 4.0 Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c604t-d4cbfc3b105673e071bbcd3bd7074ecd8c9e03985832d85c2fa0b92a0bd7d0973 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3476912 |
PMID | 22773702 |
PQID | 1223844351 |
PQPubID | 47715 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3476912 proquest_miscellaneous_1115064383 proquest_journals_1223844351 gale_infotracmisc_A309727880 gale_infotracgeneralonefile_A309727880 gale_infotracacademiconefile_A309727880 pubmed_primary_22773702 pascalfrancis_primary_26674746 crossref_citationtrail_10_2337_dc12_0116 crossref_primary_10_2337_dc12_0116 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-11-01 |
PublicationDateYYYYMMDD | 2012-11-01 |
PublicationDate_xml | – month: 11 year: 2012 text: 2012-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Alexandria, VA |
PublicationPlace_xml | – name: Alexandria, VA – name: United States – name: Alexandria |
PublicationTitle | Diabetes care |
PublicationTitleAlternate | Diabetes Care |
PublicationYear | 2012 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | Aekplakorn (2022031220344044500_B29) 2006; 29 Kuroda (2022031220344044500_B10) 2005; 28 Katz (2022031220344044500_B24) 2000; 85 Shao (2022031220344044500_B9) 2012; 7 International Expert Committee (2022031220344044500_B19) 2009; 32 Li (2022031220344044500_B28) 2009; 302 Kochhar (2022031220344044500_B6) 2008; 52 Matthews (2022031220344044500_B22) 1985; 28 Nishiyama (2022031220344044500_B11) 2005; 53 American Diabetes Association (2022031220344044500_B17) 2012; 35 Nauck (2022031220344044500_B25) 2007; 9 Alberti (2022031220344044500_B21) 2005; 366 Dupont (2022031220344044500_B26) 1998; 19 Kanitkar (2022031220344044500_B14) 2008; 155 Chainani-Wu (2022031220344044500_B20) 2003; 9 Hogan (2022031220344044500_B2) 2003; 26 Seo (2022031220344044500_B15) 2008; 52 Collins (2022031220344044500_B31) 2006; 29 Hanley (2022031220344044500_B5) 2010; 33 Tura (2022031220344044500_B23) 2003; 285 Aggarwal (2022031220344044500_B7) 2010; 30 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2022031220344044500_B18) 1997; 20 Wild (2022031220344044500_B1) 2004; 27 Hsu (2022031220344044500_B30) 2007; 595 Knowler (2022031220344044500_B3) 2002; 346 Jacob (2022031220344044500_B13) 2007 Yokoyama (2022031220344044500_B27) 2006; 91 Jang (2022031220344044500_B16) 2008; 57 Yeh (2022031220344044500_B32) 2003; 26 Rydén (2022031220344044500_B4) 2007; 28 Weisberg (2022031220344044500_B8) 2008; 149 Jain (2022031220344044500_B12) 2009; 11 16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62 19584347 - JAMA. 2009 Jul 8;302(2):179-88 18940397 - Metabolism. 2008 Nov;57(11):1576-83 12670835 - Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E155-62 18398869 - Mol Nutr Food Res. 2008 Sep;52(9):995-1004 22187471 - Diabetes Care. 2012 Jan;35 Suppl 1:S4-S10 20009095 - Diabetes Care. 2010 Mar;33(3):608-13 17300595 - Diabetes Obes Metab. 2007 Mar;9(2):194-205 12610059 - Diabetes Care. 2003 Mar;26(3):917-32 11832527 - N Engl J Med. 2002 Feb 7;346(6):393-403 18274631 - PPAR Res. 2007;2007:89369 12663610 - Diabetes Care. 2003 Apr;26(4):1277-94 19502545 - Diabetes Care. 2009 Jul;32(7):1327-34 19585751 - Indian J Physiol Pharmacol. 2008 Oct-Dec;52(4):327-54 20420526 - Annu Rev Nutr. 2010 Aug 21;30:173-99 17220161 - Eur Heart J. 2007 Jan;28(1):88-136 3899825 - Diabetologia. 1985 Jul;28(7):412-9 16567846 - Diabetes Care. 2006 Apr;29(4):945-6 9875838 - Control Clin Trials. 1998 Dec;19(6):589-601 15713005 - J Agric Food Chem. 2005 Feb 23;53(4):959-63 9203460 - Diabetes Care. 1997 Jul;20(7):1183-97 16234307 - J Clin Endocrinol Metab. 2006 Jan;91(1):290-4 18695642 - Br J Pharmacol. 2008 Nov;155(5):702-13 10902785 - J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10 15111519 - Diabetes Care. 2004 May;27(5):1047-53 18976114 - Antioxid Redox Signal. 2009 Feb;11(2):241-9 15863912 - Biol Pharm Bull. 2005 May;28(5):937-9 22253696 - PLoS One. 2012;7(1):e28784 17569225 - Adv Exp Med Biol. 2007;595:471-80 12676044 - J Altern Complement Med. 2003 Feb;9(1):161-8 16873795 - Diabetes Care. 2006 Aug;29(8):1872-7 23906104 - Explore (NY). 2013 Jul-Aug;9(4):251-4 18403477 - Endocrinology. 2008 Jul;149(7):3549-58 |
References_xml | – volume: 155 start-page: 702 year: 2008 ident: 2022031220344044500_B14 article-title: Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo publication-title: Br J Pharmacol doi: 10.1038/bjp.2008.311 – volume: 32 start-page: 1327 year: 2009 ident: 2022031220344044500_B19 article-title: International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes publication-title: Diabetes Care doi: 10.2337/dc09-9033 – volume: 366 start-page: 1059 year: 2005 ident: 2022031220344044500_B21 article-title: The metabolic syndrome—a new worldwide definition publication-title: Lancet doi: 10.1016/S0140-6736(05)67402-8 – volume: 285 start-page: E155 year: 2003 ident: 2022031220344044500_B23 article-title: Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00104.2002 – volume: 29 start-page: 945 year: 2006 ident: 2022031220344044500_B31 article-title: An exploratory study into the effectiveness of a combination of traditional Chinese herbs in the management of type 2 diabetes publication-title: Diabetes Care doi: 10.2337/diacare.29.04.06.dc05-2330 – volume: 9 start-page: 161 year: 2003 ident: 2022031220344044500_B20 article-title: Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa) publication-title: J Altern Complement Med doi: 10.1089/107555303321223035 – volume: 26 start-page: 917 year: 2003 ident: 2022031220344044500_B2 article-title: Economic costs of diabetes in the US in 2002 publication-title: Diabetes Care doi: 10.2337/diacare.26.3.917 – volume: 595 start-page: 471 year: 2007 ident: 2022031220344044500_B30 article-title: Clinical studies with curcumin publication-title: Adv Exp Med Biol doi: 10.1007/978-0-387-46401-5_21 – volume: 85 start-page: 2402 year: 2000 ident: 2022031220344044500_B24 article-title: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.85.7.6661 – volume: 9 start-page: 194 year: 2007 ident: 2022031220344044500_B25 article-title: Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial publication-title: Diabetes Obes Metab doi: 10.1111/j.1463-1326.2006.00704.x – volume: 52 start-page: 995 year: 2008 ident: 2022031220344044500_B15 article-title: Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice publication-title: Mol Nutr Food Res doi: 10.1002/mnfr.200700184 – volume: 57 start-page: 1576 year: 2008 ident: 2022031220344044500_B16 article-title: Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters publication-title: Metabolism doi: 10.1016/j.metabol.2008.06.014 – volume: 27 start-page: 1047 year: 2004 ident: 2022031220344044500_B1 article-title: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 publication-title: Diabetes Care doi: 10.2337/diacare.27.5.1047 – volume: 28 start-page: 88 year: 2007 ident: 2022031220344044500_B4 article-title: Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary publication-title: Eur Heart J – volume: 7 start-page: e28784 year: 2012 ident: 2022031220344044500_B9 article-title: Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes publication-title: PLoS ONE doi: 10.1371/journal.pone.0028784 – volume: 53 start-page: 959 year: 2005 ident: 2022031220344044500_B11 article-title: Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice publication-title: J Agric Food Chem doi: 10.1021/jf0483873 – volume: 28 start-page: 412 year: 1985 ident: 2022031220344044500_B22 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 302 start-page: 179 year: 2009 ident: 2022031220344044500_B28 article-title: Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis publication-title: JAMA doi: 10.1001/jama.2009.976 – volume: 29 start-page: 1872 year: 2006 ident: 2022031220344044500_B29 article-title: A risk score for predicting incident diabetes in the Thai population publication-title: Diabetes Care doi: 10.2337/dc05-2141 – volume: 33 start-page: 608 year: 2010 ident: 2022031220344044500_B5 article-title: Effect of Rosiglitazone and Ramipril on beta-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial publication-title: Diabetes Care doi: 10.2337/dc09-1579 – volume: 11 start-page: 241 year: 2009 ident: 2022031220344044500_B12 article-title: Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats publication-title: Antioxid Redox Signal doi: 10.1089/ars.2008.2140 – volume: 20 start-page: 1183 year: 1997 ident: 2022031220344044500_B18 article-title: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus publication-title: Diabetes Care doi: 10.2337/diacare.20.7.1183 – volume: 19 start-page: 589 year: 1998 ident: 2022031220344044500_B26 article-title: Power and sample size calculations for studies involving linear regression publication-title: Control Clin Trials doi: 10.1016/S0197-2456(98)00037-3 – volume: 30 start-page: 173 year: 2010 ident: 2022031220344044500_B7 article-title: Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals publication-title: Annu Rev Nutr doi: 10.1146/annurev.nutr.012809.104755 – volume: 28 start-page: 937 year: 2005 ident: 2022031220344044500_B10 article-title: Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice publication-title: Biol Pharm Bull doi: 10.1248/bpb.28.937 – volume: 35 start-page: S4 year: 2012 ident: 2022031220344044500_B17 article-title: Executive summary: Standards of medical care in diabetes—2012 publication-title: Diabetes Care doi: 10.2337/dc12-s004 – volume: 26 start-page: 1277 year: 2003 ident: 2022031220344044500_B32 article-title: Systematic review of herbs and dietary supplements for glycemic control in diabetes publication-title: Diabetes Care doi: 10.2337/diacare.26.4.1277 – volume: 91 start-page: 290 year: 2006 ident: 2022031220344044500_B27 article-title: Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-2549 – volume: 149 start-page: 3549 year: 2008 ident: 2022031220344044500_B8 article-title: Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity publication-title: Endocrinology doi: 10.1210/en.2008-0262 – start-page: 89369 volume-title: PPAR Res year: 2007 ident: 2022031220344044500_B13 article-title: Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation. – volume: 346 start-page: 393 year: 2002 ident: 2022031220344044500_B3 article-title: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin publication-title: N Engl J Med doi: 10.1056/NEJMoa012512 – volume: 52 start-page: 327 year: 2008 ident: 2022031220344044500_B6 article-title: Dietary spices in health and diseases (II) publication-title: Indian J Physiol Pharmacol – reference: 18274631 - PPAR Res. 2007;2007:89369 – reference: 17300595 - Diabetes Obes Metab. 2007 Mar;9(2):194-205 – reference: 11832527 - N Engl J Med. 2002 Feb 7;346(6):393-403 – reference: 9875838 - Control Clin Trials. 1998 Dec;19(6):589-601 – reference: 10902785 - J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10 – reference: 18940397 - Metabolism. 2008 Nov;57(11):1576-83 – reference: 16567846 - Diabetes Care. 2006 Apr;29(4):945-6 – reference: 18976114 - Antioxid Redox Signal. 2009 Feb;11(2):241-9 – reference: 12610059 - Diabetes Care. 2003 Mar;26(3):917-32 – reference: 20420526 - Annu Rev Nutr. 2010 Aug 21;30:173-99 – reference: 15713005 - J Agric Food Chem. 2005 Feb 23;53(4):959-63 – reference: 12670835 - Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E155-62 – reference: 22187471 - Diabetes Care. 2012 Jan;35 Suppl 1:S4-S10 – reference: 18695642 - Br J Pharmacol. 2008 Nov;155(5):702-13 – reference: 19585751 - Indian J Physiol Pharmacol. 2008 Oct-Dec;52(4):327-54 – reference: 9203460 - Diabetes Care. 1997 Jul;20(7):1183-97 – reference: 23906104 - Explore (NY). 2013 Jul-Aug;9(4):251-4 – reference: 20009095 - Diabetes Care. 2010 Mar;33(3):608-13 – reference: 17569225 - Adv Exp Med Biol. 2007;595:471-80 – reference: 16234307 - J Clin Endocrinol Metab. 2006 Jan;91(1):290-4 – reference: 15111519 - Diabetes Care. 2004 May;27(5):1047-53 – reference: 15863912 - Biol Pharm Bull. 2005 May;28(5):937-9 – reference: 19584347 - JAMA. 2009 Jul 8;302(2):179-88 – reference: 12663610 - Diabetes Care. 2003 Apr;26(4):1277-94 – reference: 3899825 - Diabetologia. 1985 Jul;28(7):412-9 – reference: 18398869 - Mol Nutr Food Res. 2008 Sep;52(9):995-1004 – reference: 12676044 - J Altern Complement Med. 2003 Feb;9(1):161-8 – reference: 22253696 - PLoS One. 2012;7(1):e28784 – reference: 17220161 - Eur Heart J. 2007 Jan;28(1):88-136 – reference: 19502545 - Diabetes Care. 2009 Jul;32(7):1327-34 – reference: 18403477 - Endocrinology. 2008 Jul;149(7):3549-58 – reference: 16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62 – reference: 16873795 - Diabetes Care. 2006 Aug;29(8):1872-7 |
SSID | ssj0004488 |
Score | 2.5855532 |
Snippet | To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population.
This randomized, double-blinded,... To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population. This randomized, double-blinded,... To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population.OBJECTIVETo assess the efficacy of... |
SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2121 |
SubjectTerms | Biological and medical sciences Curcumin - therapeutic use Diabetes Diabetes Mellitus, Type 2 - prevention & control Diabetes. Impaired glucose tolerance Disease Double-Blind Method Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Health care Humans Intervention Lifestyles Male Medical sciences Metabolic diseases Middle Aged Miscellaneous Nutrition research Original Research Pharmaceuticals Plant Extracts - therapeutic use Prediabetic State - drug therapy Prevention Public health. Hygiene Public health. Hygiene-occupational medicine Treatment Outcome Turmeric Type 2 diabetes |
Title | Curcumin Extract for Prevention of Type 2 Diabetes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22773702 https://www.proquest.com/docview/1223844351 https://www.proquest.com/docview/1115064383 https://pubmed.ncbi.nlm.nih.gov/PMC3476912 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEB_0DkQQ8dvqukQR9aVcm6RN8yTnusepeIh4sG-l-ageaLted8E_35k2u3uVxZdAyRDCJJPMr5n5DcBL77T3de5iYbgkgJLGhc11XBnpXc6JYa6P8j3LT8_lx0W2CD_cuhBWuTkT-4PatZb-kR-leI8VEi_39O3yd0xVo-h1NZTQuA6HRF1GIV1qoXZ5kbKvO0koIM605gOzEBdCHTnbhyRQmfMr91E4lW8tqw41VA-lLfb5nv-GUF65k07uwO3gTLLjYfXvwjXf3IMbn8Nz-X3gs_WlXf-6aNj8z4rSoRi6qGzD2tQ2rK0ZAVHGWYiM6R7A-cn82-w0DkUSYpsnchU7aU1thUE_KVfCo8dgjHXCOIXOgafMf-0ToYsMTdcVmeV1lRjNsXHKEVfPQzho2sY_BiYybRG9WKo9LwttdY14UfvM6MpoI1wEbzaqKm1gEKdCFj9LRBKk1ZK0WpJWI3ixFV0OtBn7hF6TvksyJVJCFTICcDZESlUeC-IWQoyeRPBqJPl9oOTeJzgZCaKt2FH3dLS027mhm4K4SuKUJpu1LoMxd-Vu60XwfNtNQ1OAWuPbdUdAiqj_EO9H8GjYGrvBuVJCJTwCNdo0WwGi-B73NBc_eqpvIVWuU_7k_9N6CjfRj-NDiuQEDlaXa_8MfaWVmfYGgW0xS6dw-G5-9uUrfr3_8OkvmpYUgw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQSVEOJNYCkBAeUSddd24viAUClbbWm7QqiVegvxI6USJEuzK-BP8RuZyWO3QStuveTikWWNx5754plvAF46q5zLIhtwzQQBlGEQm0gFqRbORowY5qos30k0PhEfT8PTNfjT1sJQWmV7J1YXtS0M_SPfHqIfiwU69-G76Y-AukbR62rbQqM2iwP3-ydCtvLt_gfc31eM7Y2Od8dB01UgMNFAzAIrjM4M19RyXnKHLlZrY7m2Er2po1J55QZcxSHauo1Dw7J0oBXDj5WWyG1w3muwLjhCmR6svx9NPn1eVmKKqtMl4Y4gVIrVXEaMc7ltTZUEQY3VL3nAxg_cnKYl7klWN9NYFe3-m7R5yQvu3YZbTfjq79T2dgfWXH4Xrh81D_T3gO3OL8z8-3nuj37NqADLx6DYb3miitwvMp-gr8_8JhenvA8nV6LAB9DLi9w9Ap-HyiBeMtTtXsTKqAwRqnKhVqlWmlsP3rSqSkzDWU6tM74liF1IqwlpNSGtevBiITqtiTpWCW2RvhM6vKSEtKlBwNUQDVayw4nNSOKd5sHrjuRZTQK-SrDfEcTTaTrDm52tXawNAyNEcgKX1G_3OmmujzJZGrsHzxfDNDWlxOWumJcE3YhskMfcg4e1aSwnZ1JyOWAeyI7RLASIVLw7kp9_rcjFuZCRGrLH_1_WM7gxPj46TA73JwdPYAOjSFYXaPahN7uYu6cYqc30ZnM8fPhy1SfyL9P8UDA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9RADLZKkSokhHgTWMqAeF2i3Z2ZZDIHhKq2q5ZCxYFKewuZR2ilkizNroC_xq_DzmO3QStuveQy1sjy2GM7Y38GeOmd9j6PXSgMl5SgjMPExjrMjPQu5oQwV1f5HscHJ_LDNJpuwJ-uF4bKKrs7sb6oXWnpH_lwjH4skejcx8O8LYv4vDd5P_sR0gQpemntxmk0KnLkf__E9K16d7iHZ_2K88n-l92DsJ0wENp4JOehk9bkVhgaP6-ER3drjHXCOIWe1VPbvPYjoZMI9d4lkeV5NjKa48cpR0A3uO81uK6QK7IxNVWrnkxZz7ykDCSMtOYNqhEXQg2drcshaMT6JV_YeoSbs6zC08mbsRrr4t5_yzcv-cPJbbjVBrJsp9G8O7Dhi7uw9al9qr8HfHdxYRffzwq2_2tOrVgMw2PWIUaVBStzRkkw46ytyqnuw8mViO8BbBZl4R8BE5G2mDlZmnsvE211jrmq9pHRmdFGuADedqJKbYteTkM0zlPMYkiqKUk1JakG8GJJOmsgO9YRvSF5p2TGJISs7UZAbggQK90RhGuk8HYL4HWP8lsDB76OcNAjRDu1veXt3tEuecMQCXM6iSwNurNO24ukSldqH8Dz5TJtTcVxhS8XFSVxBDsoEhHAw0Y1VptzpYQa8QBUT2mWBAQv3l8pzk5rmHEhVazH_PH_2XoGW2iH6cfD46MncAPDSd50ag5gc36x8E8xZJub7do2GHy9amP8C8UaUwA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Curcumin+Extract+for+Prevention+of+Type+2+Diabetes&rft.jtitle=Diabetes+care&rft.au=Chuengsamarn%2C+Somlak&rft.au=Rattanamongkolgul%2C+Suthee&rft.au=Luechapudiporn%2C+Rataya&rft.au=Phisalaphong%2C+Chada&rft.date=2012-11-01&rft.issn=0149-5992&rft.eissn=1935-5548&rft.volume=35&rft.issue=11&rft.spage=2121&rft.epage=2127&rft_id=info:doi/10.2337%2Fdc12-0116&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_dc12_0116 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon |